IDEAYA Biosciences (IDYA) Competitors $24.27 -0.08 (-0.33%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$24.28 +0.01 (+0.04%) As of 08/1/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. VRNA, BPMC, LEGN, ROIV, RGC, ELAN, RVMD, GRFS, TGTX, and NUVLShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Verona Pharma PLC American Depositary Share (VRNA), Blueprint Medicines (BPMC), Legend Biotech (LEGN), Roivant Sciences (ROIV), Regencell Bioscience (RGC), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Grifols (GRFS), TG Therapeutics (TGTX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Verona Pharma PLC American Depositary Share Blueprint Medicines Legend Biotech Roivant Sciences Regencell Bioscience Elanco Animal Health Revolution Medicines Grifols TG Therapeutics Nuvalent IDEAYA Biosciences (NASDAQ:IDYA) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings. Which has more volatility & risk, IDYA or VRNA? IDEAYA Biosciences has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Does the media refer more to IDYA or VRNA? In the previous week, Verona Pharma PLC American Depositary Share had 4 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 11 mentions for Verona Pharma PLC American Depositary Share and 7 mentions for IDEAYA Biosciences. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.45 beat IDEAYA Biosciences' score of 0.49 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEAYA Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Verona Pharma PLC American Depositary Share 8 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, IDYA or VRNA? Verona Pharma PLC American Depositary Share has higher revenue and earnings than IDEAYA Biosciences. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEAYA Biosciences$7M303.65-$274.48M-$3.59-6.76Verona Pharma PLC American Depositary Share$42.28M211.78-$173.42M-$2.00-52.59 Is IDYA or VRNA more profitable? IDEAYA Biosciences' return on equity of -29.28% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets IDEAYA BiosciencesN/A -29.28% -27.68% Verona Pharma PLC American Depositary Share N/A -69.65%-28.00% Do insiders and institutionals hold more shares of IDYA or VRNA? 98.3% of IDEAYA Biosciences shares are owned by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 2.5% of IDEAYA Biosciences shares are owned by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts rate IDYA or VRNA? IDEAYA Biosciences presently has a consensus price target of $48.09, suggesting a potential upside of 98.15%. Verona Pharma PLC American Depositary Share has a consensus price target of $109.00, suggesting a potential upside of 3.63%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe IDEAYA Biosciences is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEAYA Biosciences 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.77Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15 SummaryIDEAYA Biosciences beats Verona Pharma PLC American Depositary Share on 8 of the 15 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$3.00B$5.47B$9.53BDividend YieldN/A2.43%4.74%4.08%P/E Ratio-6.7617.6228.6723.80Price / Sales303.65268.97422.2688.08Price / CashN/A41.9535.4557.96Price / Book1.988.508.275.55Net Income-$274.48M-$55.06M$3.24B$259.03M7 Day Performance-0.94%-3.98%-3.63%-4.56%1 Month Performance10.72%9.59%4.40%4.49%1 Year Performance-39.46%6.72%25.97%18.05% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences4.0628 of 5 stars$24.27-0.3%$48.09+98.1%-42.8%$2.13B$7M-6.7680Upcoming EarningsVRNAVerona Pharma PLC American Depositary Share2.1781 of 5 stars$105.09-0.2%$109.00+3.7%+365.2%$8.54B$118.54M-52.5530Positive NewsUpcoming EarningsShort Interest ↑BPMCBlueprint Medicines1.0958 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640Upcoming EarningsLEGNLegend Biotech3.5818 of 5 stars$41.51-4.3%$73.33+76.7%-29.5%$7.97B$627.24M-70.352,609Positive NewsROIVRoivant Sciences1.8308 of 5 stars$11.35-1.7%$16.50+45.4%+6.5%$7.85B$29.05M-45.40860Upcoming EarningsRGCRegencell Bioscience0.0453 of 5 stars$13.80-8.3%N/AN/A$7.44BN/A0.0010Positive NewsELANElanco Animal Health3.7888 of 5 stars$14.59-2.2%$16.17+10.8%+5.9%$7.41B$4.43B19.729,000Positive NewsUpcoming EarningsRVMDRevolution Medicines4.4642 of 5 stars$37.26-1.7%$68.91+84.9%-19.1%$7.06B$11.58M-9.32250News CoveragePositive NewsUpcoming EarningsGRFSGrifols3.0861 of 5 stars$10.09-0.1%$10.30+2.1%+41.1%$6.94B$7.81B8.6223,822Dividend AnnouncementTGTXTG Therapeutics4.0717 of 5 stars$35.99-2.5%$43.80+21.7%+85.0%$5.86B$329M149.96290Positive NewsUpcoming EarningsNUVLNuvalent3.1791 of 5 stars$81.94+0.7%$119.60+46.0%+2.0%$5.85BN/A-18.6740Positive News Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share Alternatives Blueprint Medicines Alternatives Legend Biotech Alternatives Roivant Sciences Alternatives Regencell Bioscience Alternatives Elanco Animal Health Alternatives Revolution Medicines Alternatives Grifols Alternatives TG Therapeutics Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
